183 related articles for article (PubMed ID: 38602413)
1. Naphthylisoquinoline alkaloids: novel agents against the causative pathogens of eumycetoma and actinomycetoma-
Khalid SA; Abd Algaffar S; Tajuddeen N; Lombe BK; Bringmann G
Antimicrob Agents Chemother; 2024 May; 68(5):e0161223. PubMed ID: 38602413
[TBL] [Abstract][Full Text] [Related]
2. Antifungal Activity of Natural Naphthoquinones and Anthraquinones against Madurella mycetomatis.
Ma J; Todd M; van de Sande WWJ; Biersack B
Chem Biodivers; 2023 May; 20(5):e202300151. PubMed ID: 37067830
[TBL] [Abstract][Full Text] [Related]
3. Novel Compound MMV1804559 from the Global Health Priority Box Exhibits In Vitro and In Vivo Activity against
Ma J; Eadie K; Schippers M; Fahal A; Laleu B; Verbon A; van de Sande WWJ
Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892422
[TBL] [Abstract][Full Text] [Related]
4. The synthetic synergistic cinnamon oil CIN-102 is active against Madurella mycetomatis, the most common causative agent of mycetoma.
Konings M; Eadie K; Lim W; Fahal AH; Mouton J; Tesse N; van de Sande WWJ
PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009488. PubMed ID: 34106933
[TBL] [Abstract][Full Text] [Related]
5. Screening the pandemic response box identified benzimidazole carbamates, Olorofim and ravuconazole as promising drug candidates for the treatment of eumycetoma.
Lim W; Nyuykonge B; Eadie K; Konings M; Smeets J; Fahal A; Bonifaz A; Todd M; Perry B; Samby K; Burrows J; Verbon A; van de Sande W
PLoS Negl Trop Dis; 2022 Feb; 16(2):e0010159. PubMed ID: 35120131
[TBL] [Abstract][Full Text] [Related]
6. Niclosamide Is Active In Vitro against Mycetoma Pathogens.
Mahmoud AB; Abd Algaffar S; van de Sande W; Khalid S; Kaiser M; Mäser P
Molecules; 2021 Jun; 26(13):. PubMed ID: 34209118
[TBL] [Abstract][Full Text] [Related]
7. Combining two antifungal agents does not enhance survival of Galleria mellonella larvae infected with Madurella mycetomatis.
Eadie K; Parel F; Helvert-van Poppel M; Fahal A; van de Sande W
Trop Med Int Health; 2017 Jun; 22(6):696-702. PubMed ID: 28342219
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting DHN- and DOPA-melanin biosynthesis pathway increased the therapeutic value of itraconazole in Madurella mycetomatis infected Galleria mellonella.
Lim W; Konings M; Parel F; Eadie K; Strepis N; Fahal A; Verbon A; van de Sande WWJ
Med Mycol; 2022 Feb; 60(2):. PubMed ID: 35064672
[TBL] [Abstract][Full Text] [Related]
9. Addressing the most neglected diseases through an open research model: The discovery of fenarimols as novel drug candidates for eumycetoma.
Lim W; Melse Y; Konings M; Phat Duong H; Eadie K; Laleu B; Perry B; Todd MH; Ioset JR; van de Sande WWJ
PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006437. PubMed ID: 29698504
[TBL] [Abstract][Full Text] [Related]
10. Amphotericin B and terbinafine but not the azoles prolong survival in Galleria mellonella larvae infected with Madurella mycetomatis.
Kloezen W; Parel F; Brüggemann R; Asouit K; Helvert-van Poppel M; Fahal A; Mouton J; van de Sande W
Med Mycol; 2018 Jun; 56(4):469-478. PubMed ID: 28992315
[TBL] [Abstract][Full Text] [Related]
11. The combination of manogepix and itraconazole is synergistic and inhibits the growth of Madurella mycetomatis in vitro but not in vivo.
Konings M; Eadie K; Strepis N; Nyuykonge B; Fahal AH; Verbon A; van de Sande WWJ
Med Mycol; 2023 Nov; 61(11):. PubMed ID: 37960934
[TBL] [Abstract][Full Text] [Related]
12. Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole.
Nyuykonge B; Lim W; van Amelsvoort L; Bonifaz A; Fahal A; Badali H; Abastabar M; Verbon A; van de Sande W
Mycoses; 2022 Jun; 65(6):650-655. PubMed ID: 35398930
[TBL] [Abstract][Full Text] [Related]
13. Mycetoma in north-western Yemen: Clinico-epidemiological and histopathological study.
Khatri ML; Al Kubati SAS; Gaffer IA; Majeed SMA
Indian J Dermatol Venereol Leprol; 2022; 88(5):615-622. PubMed ID: 35389029
[TBL] [Abstract][Full Text] [Related]
14. A Madurella mycetomatis Grain Model in Galleria mellonella Larvae.
Kloezen W; van Helvert-van Poppel M; Fahal AH; van de Sande WW
PLoS Negl Trop Dis; 2015; 9(7):e0003926. PubMed ID: 26173126
[TBL] [Abstract][Full Text] [Related]
15. Madurella mycetomatis is not susceptible to the echinocandin class of antifungal agents.
van de Sande WW; Fahal AH; Bakker-Woudenberg IA; van Belkum A
Antimicrob Agents Chemother; 2010 Jun; 54(6):2738-40. PubMed ID: 20350944
[TBL] [Abstract][Full Text] [Related]
16. Mycetoma: a unique neglected tropical disease.
Zijlstra EE; van de Sande WWJ; Welsh O; Mahgoub ES; Goodfellow M; Fahal AH
Lancet Infect Dis; 2016 Jan; 16(1):100-112. PubMed ID: 26738840
[TBL] [Abstract][Full Text] [Related]
17. The in vitro antifungal activity of sudanese medicinal plants against Madurella mycetomatis, the eumycetoma major causative agent.
Elfadil H; Fahal A; Kloezen W; Ahmed EM; van de Sande W
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003488. PubMed ID: 25768115
[TBL] [Abstract][Full Text] [Related]
18. A Falciformispora senegalensis grain model in Galleria mellonella larvae.
Ma J; Konings M; Verbon A; van de Sande WWJ
Med Mycol; 2023 Aug; 61(8):. PubMed ID: 37451815
[TBL] [Abstract][Full Text] [Related]
19. An updated list of eumycetoma causative agents and their differences in grain formation and treatment response.
van de Sande WWJ; Fahal AH
Clin Microbiol Rev; 2024 Jun; 37(2):e0003423. PubMed ID: 38690871
[TBL] [Abstract][Full Text] [Related]
20. In vitro antifungal activity of isavuconazole against Madurella mycetomatis.
Kloezen W; Meis JF; Curfs-Breuker I; Fahal AH; van de Sande WW
Antimicrob Agents Chemother; 2012 Nov; 56(11):6054-6. PubMed ID: 22964246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
